In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OUTLOOK 2021

Annual industry ranking and forecast

Opportunities For Medtech In Mental Health

Executive Summary

With the global pandemic leading to a big rise in mental health issues, medtech could have a role to play. In Vivo explores transcranial magnetic stimulation systems that are being used to treat severe anxiety and depression, among other indications. As well as the skyrocketing use of telehealth, apps and light therapy for mental health indications.  

You may also be interested in...



Oura Debuts New Stress Analyzers, Partnership With Headspace

At HLTH, Oura debuted stress-focused features aimed to help wearers identify stress triggers, reduce stress, as well as a new AI-powered tool that allows its members digital journaling. Oura’s new partnership with the mindfulness app maker Headspace, lets users access stress-relieving content, such as meditations.

Oura Debuts New Stress Analyzers, Partnership With Headspace At HLTH

At HLTH, Oura debuted stress-focused features aimed to help wearers identify stress triggers, reduce stress, as well as a new AI-powered tool that allows its members digital journaling. Oura’s new partnership with the mindfulness app maker Headspace, lets users access stress-relieving content, such as meditations.

Rock Health Reports Record Digital Health Funding Of $5.4Bn In H1 2020, Sees Potential For Record-Year Funding

Digital health funding is on track for the largest funding year ever amid the COVID-driven demand for telehealth and remote monitoring of patients. However, a large second wave of the pandemic could reverse that trend.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

IV124573

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel